Pittaway 1989.
Study characteristics | |||
Patient sampling |
Primary objective: to determine whether serum CA‐125 would be useful in differentiating between pelvic pain caused by endometriosis and that from other causes Participants: reproductive‐aged women scheduled for laparoscopy or laparotomy for investigation of chronic pelvic pain with or without infertility Selection criteria: inclusion criteria: reproductive age, pain lasting at least 3 months Study design: cross‐sectional single‐gate design, prospective recruitment |
||
Patient characteristics and setting |
Clinical presentation: pelvic pain ± infertility Age: mean age 28.9 years, range 16‐39 (endometriosis) and 26.7 years, range 14‐44 years (controls) Number of participants enrolled: 180 women Number of participants available for analysis: 163 women (all in in late follicular phase of menstrual cycle, day 7‐10) Setting: Section on Reproductive Endocrinilogy, Wake Forest School of Medicine, tertiary referral centre Place of study: Winston Salem, North Carolina, USA Period of study: over 30 months period, dates not provided Language: English |
||
Index tests |
Index test: CA‐125 Details of the index test procedure as stated: serum CA‐125 was measured in duplicate in using an immunoradiometric assay (Centocor, Malvern, PA); sample handling described, reference to a source describing laboratory technique Threshold for positive result: CA‐125 ≥16 U/ml; pre‐specified Examiners: no information provided; operators of index test were blinded to surgical data Interobserver variability: not reported |
||
Target condition and reference standard(s) |
Target condition: endometriosis Prevalence of target condition in the sample: n = 82/163 (50%): stage I‐II 54, stage III‐IV 28; controls n = 81: normal pelvis ‐ 15, adhesions ‐ 27, chronic PID ‐ 28, other ‐ 11 Reference standard: laparoscopy n = 163 (100%) Description of positive case definition by reference standard test as reported: surgical diagnosis; staging according to the rASRM classification Examiners: no information provided; CA‐125 levels were not known at the time of surgery |
||
Flow and timing |
Time interval between index test and reference standard: preoperative 7‐10 days before onset of last menses Withdrawals: 17 women were excluded from the study (were still menstruating on a day of sample collection) |
||
Comparative | |||
Key conclusions by the authors | Determination of CA‐125 may assist in the evaluation and treatment of women with chronic pelvic pain | ||
Conflict of interest | Not reported | ||
Notes | The reported data enabled calculation of the diagnostic estimates per severity of endometriosis ‐ not presented in this review | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Was a 'two‐gate' design avoided? | Yes | ||
Unclear | Low | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Was a cycle phase considered in interpretation of the result of index test? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Low |